Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability
Clinical trial NCT00257114 · COMPLETED
Trial details
- NCT number
- NCT00257114
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Primary completion
- 2007-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.